Skip to main content
Log in

Reply to klemm

  • Letters To The Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Arnt J, Perregaad J (1987) Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behavior of rats with hemitransection. Eur J Pharmacol 143:45–53

    Article  PubMed  Google Scholar 

  • Arnt J, Hyttel J, Perregaad J (1987) Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behavior in rats. Eur J Pharmacol 133:137–145

    Article  PubMed  Google Scholar 

  • Braun AR, Chase TN (1986) Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131:301–306

    Article  PubMed  Google Scholar 

  • Carlson JH, Bergstrom DA, Walters JR (1987) Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Brain Res 400:205–218

    Article  PubMed  Google Scholar 

  • Christensen AV, Arnt J, Hyttel J, Larsen J-J, Svendsen O (1984) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529–1540

    Article  PubMed  Google Scholar 

  • Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor protein in brain with subtype-specific antibodies. J Neurosci 11:3218–3226

    PubMed  Google Scholar 

  • Mei L, Roeske WR, Yamamura HI (1989) Molecular pharmacology of muscarinic receptor heterogeneity. Life Sci 45:1831–1851

    Article  PubMed  Google Scholar 

  • Robertson GS, Robertson HA (1986) Synergistic effects of D1 and D2 dopamine agonists on turning behavior in rats. Brain Res 384:387–390

    Article  PubMed  Google Scholar 

  • Sibley DR, Monsma FJ Jr (1992) Molecular biology of dopamine receptors. TIPS 13:61–69

    PubMed  Google Scholar 

  • Svendsen CN, Froimowitz M, Hrbek C, Campbell A, Kula N, Baldessarini RJ, Cohen BM, Babb S, Teicher MH, Bird ED (1988) Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain. Neuropharmacology 27:1117–1124

    Article  PubMed  Google Scholar 

  • Terai M, Usuda S, Kuroiwa I, Noshiro O, Maeno H (1983) Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors. Jpn J Pharmacol 33:749–755

    PubMed  Google Scholar 

  • Undie AS, Friedman E (1988) Differences in the cataleptogenic actions of SCH 23390 and selected classical neuroleptics. Psychopharmacology 96:311–316

    Google Scholar 

  • Wanibuchi F, Usuda S (1990) Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats. Psychopharmacology 102:339–342

    Article  PubMed  Google Scholar 

  • Weick BG, Walters JR (1987) Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Brain Res 405:234–246

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wanibuchi, F., Usuda, S. Reply to klemm. Psychopharmacology 111, 254–255 (1993). https://doi.org/10.1007/BF02245533

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245533

Navigation